Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleOMERACT 9: International Consensus Conference on Outcome Measures in Rheumatology, Kananaskis Village, Alberta, Canada, May 27–31, 2008

Reducing Invasiveness, Duration, and Cost of Magnetic Resonance Imaging in Rheumatoid Arthritis by Omitting Intravenous Contrast Injection — Does It Change the Assessment of Inflammatory and Destructive Joint Changes by the OMERACT RAMRIS?

MIKKEL ØSTERGAARD, PHILIP G. CONAGHAN, PHILIP O’CONNOR, MARCIN SZKUDLAREK, METTE KLARLUND, PAUL EMERY, CHARLES PETERFY, HARRY GENANT, FIONA M. McQUEEN, PAUL BIRD, MARISSA LASSERE and BO EJBJERG
The Journal of Rheumatology August 2009, 36 (8) 1806-1810; DOI: https://doi.org/10.3899/jrheum.090350
MIKKEL ØSTERGAARD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mo@dadlnet.dk
PHILIP G. CONAGHAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PHILIP O’CONNOR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARCIN SZKUDLAREK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
METTE KLARLUND
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PAUL EMERY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHARLES PETERFY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HARRY GENANT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FIONA M. McQUEEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PAUL BIRD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARISSA LASSERE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BO EJBJERG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Low-field dedicated E-MRI of RA wrist and 2nd–5th MCP joints. Coronal (a-b) and axial (d-e) T1-weighted gradient-echo images and coronal STIR image (c) of the wrist and MCP joints before (a, c, and d) and after (b and e) IV contrast injection. Synovitis in 2nd and 3rd MCP joints and in the wrist (arrows) is seen both on STIR images and on contrast-enhanced images (arrows).

Tables

  • Figures
    • View popup
    Table 1.

    MRI acquisitions in Exercises A and B.

    Center/MRI unitSequencePlaneFSGdTR (ms)TE (mm)ST (mm)TI (ms)Gap (mm)FOV (mm)MatrixTime (min)
    Exercise A
      LeedsT1 SECor−−485201.5−0.1100 × 50256 × 2564.10
      1.5 T PhilipsT2 TSE SPIRCor+−20001002.0−0.2100 × 100198 × 2563.44
      GyroscanT1 SEAx−+/−485201.5−0.1100 × 50205 × 2563.21
    T1 SPIRCor++450201.5−0.1100 × 100192 × 2568.44
      CopenhagenT1 SECor−+/−600153.0−0.0109 × 145192 × 2563.53
      1.0 T SiemensT1 SEAx−+/−600−700153.0−0.0109 × 145192 × 2563.53–4.32
      ImpactSTIRCor−−4500303.01500.0108 × 145182 × 2565.5
    Exercise B
      Copenhagen3D-GECor/Ax−+/−30181.0−0.0140 × 140256 × 2566.5
      0.2 T Esaote
    Artoscan
    STIRCor−−1100243.0850.3140 × 140192 × 1605.5
    • FOV: field of view; FS: spectral fat saturation (+: yes; − no); Gd: IV injection of gadolinium contrast (−: sequence obtained before injection; +: sequence obtained after injection); GE: gradient echo; 3D-GE: T1-weighted 3-dimensional gradient echo sequence with subsequent multiplanar reconstruction. The flip angle was 65°. SPIR: spectral prepulse inversion recovery; ST: slice thickness; STIR: short-tau inversion recovery; T: tesla; T1-SE: T1-weighted spin-echo; TE: echo time; TI: inversion time; TR: repetition time.

    • View popup
    Table 2.

    Exercise A: detection of synovitis, bone erosion, and bone edema by unenhanced MRI, when gadolinium-enhanced MRI is considered the gold standard reference, and interobserver agreement evaluating MR images without and with gadolinium injection.

    Type of PathologyJointsImage SetsPerformance of Unenhanced (−Gd) MRI*Interobserver Agreement**
    SensitivitySpecificityPPVNPVAccuracyICCICC −Gd†ICC + Gd†
    Bone erosionMCPAll0.940.940.950.940.940.920.850.92
    MCP1.5 T, T2 FS0.950.930.950.930.940.910.810.95
    MCP1.0 T, STIR0.910.960.930.950.940.950.920.87
    WristAll0.890.840.830.930.870.870.740.73
    Bone edemaMCPAll0.710.880.730.880.830.750.630.71
    MCP1.5 T, T2 FS0.740.840.760.830.790.740.580.66
    MCP1.0 T, STIR0.720.950.700.960.920.780.730.81
    WristAll0.830.960.800.970.940.910.770.79
    SynovitisMCPAll0.900.490.900.470.840.670.610.88
    MCP1.5 T, T2 FS0.930.310.930.380.780.690.720.88
    MCP1.0 T, STIR0.860.790.830.540.770.630.400.87
    WristAll0.870.420.830.490.770.760.590.60
    • ↵* Values are means of values for observer 1 and observer 2. No major or systematic differences between observers were observed.

    • ↵** ICC: single measures intraclass correlation coefficient between readings on unenhanced and enhanced MRI (can be considered a “worst-case scenario” intraobserver ICC).

    • ↵† ICC −Gd: ICC for intraobserver agreement based on assessment of unenhanced images only; ICC + Gd: ICC for intraobserver agreement based on assessment of entire image sets, including Gd-enhanced images. PPV: positive predictive value of presence of pathology on unenhanced MRI, with Gd-enhanced MRI as the gold standard reference; NPV: negative predictive value of absence of pathology on unenhanced MRI, with Gd-enhanced MRI as the gold standard reference; MCP: metacarpophalangeal joints; STIR: short-tau inversion recovery; T: tesla; T2FS T2-weighted images with spectral fat saturation.

    • View popup
    Table 3.

    Exercise B. Detection of synovitis and bone erosion by unenhanced low-field E-MRI, when gadolinium-enhanced MRI is considered the gold standard reference.

    Type of pathologyJointsPerformance Unenhanced (−Gd) MRI*
    SensitivitySpecificityAccuracyICC**
    ErosionWrist and MCP0.930.990.970.99
    SynovitisWrist and MCP0.600.960.760.61
    • ↵* Values are means of values for observer 1 and observer 2. No major or systematic differences between observers were observed.

    • ↵** ICC single measures intraclass correlation coefficient between readings on unenhanced and enhanced MRI (this value can be considered a “worst-case” scenario intraobserver ICC).

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 36, Issue 8
1 Aug 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reducing Invasiveness, Duration, and Cost of Magnetic Resonance Imaging in Rheumatoid Arthritis by Omitting Intravenous Contrast Injection — Does It Change the Assessment of Inflammatory and Destructive Joint Changes by the OMERACT RAMRIS?
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Reducing Invasiveness, Duration, and Cost of Magnetic Resonance Imaging in Rheumatoid Arthritis by Omitting Intravenous Contrast Injection — Does It Change the Assessment of Inflammatory and Destructive Joint Changes by the OMERACT RAMRIS?
MIKKEL ØSTERGAARD, PHILIP G. CONAGHAN, PHILIP O’CONNOR, MARCIN SZKUDLAREK, METTE KLARLUND, PAUL EMERY, CHARLES PETERFY, HARRY GENANT, FIONA M. McQUEEN, PAUL BIRD, MARISSA LASSERE, BO EJBJERG
The Journal of Rheumatology Aug 2009, 36 (8) 1806-1810; DOI: 10.3899/jrheum.090350

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Reducing Invasiveness, Duration, and Cost of Magnetic Resonance Imaging in Rheumatoid Arthritis by Omitting Intravenous Contrast Injection — Does It Change the Assessment of Inflammatory and Destructive Joint Changes by the OMERACT RAMRIS?
MIKKEL ØSTERGAARD, PHILIP G. CONAGHAN, PHILIP O’CONNOR, MARCIN SZKUDLAREK, METTE KLARLUND, PAUL EMERY, CHARLES PETERFY, HARRY GENANT, FIONA M. McQUEEN, PAUL BIRD, MARISSA LASSERE, BO EJBJERG
The Journal of Rheumatology Aug 2009, 36 (8) 1806-1810; DOI: 10.3899/jrheum.090350
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Progress Towards a Core Set of Outcome Measures in Small-vessel Vasculitis. Report from OMERACT 9
  • Fibromyalgia Syndrome Module at OMERACT 9: Domain Construct
  • Content and Criterion Validity of the Preliminary Core Dataset for Clinical Trials in Fibromyalgia Syndrome
Show more OMERACT 9: International Consensus Conference on Outcome Measures in Rheumatology, Kananaskis Village, Alberta, Canada, May 27–31, 2008

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire